Resistance of tumor cells to tumor necrosis factor (original) (raw)
References
Kelker HC, Oppenheim JD, Stone-Wolff D, Henriksen-DeStefano D, Aggarwal BB, Stevenson HC, Vilcek J: Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin. Int J Cancer 36:69–73, 1985 Google Scholar
Männel DN, Moore RN, Mergenhagen SE: Macrophages as a source of tumoricidal activity (tumor necrosis factor). Infect Immun 30:523–530, 1980 Google Scholar
Mathews N: Tumor necrosis factor from the rabbit. V. Synthesis_in vitro_ by mononuclear phagocytes from various tissues of normal and BCG-injected rabits. Br J Cancer 44:418–424, 1981 Google Scholar
Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV: Human tumor necrosis factor: Precursor structure, expression, and homology to lymphotoxin. Nature 312:724–729, 1984 Google Scholar
Pennica D, Hayflick JS, Bringman TS, Palladino MA, Goeddel DV: Cloning and expression in_Escherichia coli_ of the cDNA from murine tumor necrosis factor. Proc Natl Acad Sci USA 82:6060–6064, 1985 Google Scholar
Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N: Macrophage-induced angiogenesis is mediated by tumor necrosis factor (TNF-α). Nature 329:630–632, 1987 Google Scholar
Chang RJ, Lee SH: Effects of interferon-γ and tumor necrosis factor-α on the expression of Ia antigen on a murine macrophage cell line. J Immunol 137:2853–2856, 1986 Google Scholar
Torti FM, Dieckmann B, Bentler B, Cerami A, Ringold GM: A macrophage factor inhibits adipocyte gene expression: An_in vitro_ model of cachexia. Science 229:867–869, 1985 Google Scholar
Patton JS, Shepard HM, Wilking H, Lewis GD, Aggarwal BB, Essalu TE, Gavin LA, Grunfeld C: Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc Natl Acad Sci USA 83:8313–8317, 1986 Google Scholar
Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH: Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50:555–563, 1987 Google Scholar
Urban JL, Shepard HM, Rothstein JL, Sugarman BJ, Schreiber H: Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 83:5233–5237, 1986 Google Scholar
Philip R, Epstein LB: Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon, and interleukin-1. Nature 323:86–89, 1986 Google Scholar
Feinman R, Henriksen-DeStefano D, Tsujimoto M, Vilcek J: Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J Immunol 138:635–640, 1987 Google Scholar
Le J, Vilcek J: Tumor necrosis factor and interleukin 1: Cytokines with multiple overlapping biological activities. Lab Invest 56:234–248, 1987 Google Scholar
Aiyer RA, Aggarwal BB: Tumor necrosis factors.In CRC Handbook of Cytolytic Lymphocytes and Complement: Effectors of the Immune System, Vol. II., ER Podack (ed). Boca Raton, FL, CRC Press, 1988, pp. 105–132 Google Scholar
Hibbs JB Jr: Discrimination between neoplastic and non-neoplastic cells_in vitro_ by activated macrophages. J Natl Cancer Inst 53:1487–1492, 1974 Google Scholar
Pace JL, Russell SW, Torres BA, Johnson HM, Gray PW: Recombinant mouse γ-interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol 130:2011–2013, 1983 Google Scholar
Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK: There is more than one interleukin 1. Immunol Today 7:45–56, 1986 Google Scholar
Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM: Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells_in vitro_. Science 230:943–945, 1985 Google Scholar
Lochman LB, Dinarello CA, Llansa ND, Fidler IJ: Natural and recombinant human interleukin 1-β is cytotoxic for human melanoma cells. J Immunol 136:3098–3102, 1986 Google Scholar
Balkwill FR, Lee A, Aldam G, Moodie E, Thomas JA, Tavernier J, Fiers W: Human tumor xenografts treated with recombinant tumor necrosis factor alone or in combination with interferons. Cancer Res 46:3990–3993, 1986 Google Scholar
Ruggiero V, Baglioni C: Synergistic anti-proliferative activity of interleukin 1 and tumor necrosis factor. J Immunol 138:661–663, 1987 Google Scholar
Zacharchuk CM, Drysdale BE, Mayer MM, Shin HS: Macrophage-mediated cytotoxicity: Role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor. Proc Natl Acad Sci USA 80:6341–6345, 1983 Google Scholar
Urban JL, Schreiber H: Selection of macrophage-resistant progressor tumor variants by the normal host. J Exp Med 157:642–656, 1983 Google Scholar
Goeddel DV, Aggarwal BB, Gray PW, Leung DW, Nedwin GE, Palladino MA, Patton JS, Pennica D, Shepard HM, Sugarman BJ, Wong GHW: Tumor necrosis factors: Gene structure and biological activities.In Cold Spring Harbor Symposia on Quantitative Biology, Vol. LI. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1986, pp 597–609 Google Scholar
Kull FC, Jacobs S, Cuatrecasas P: Cellular receptor for125I-labeled tumor necrosis factor. Specific binding, affinity labeling, and relationship to sensitivity. Proc Natl Acad Sci USA 82:5756–5760, 1985 Google Scholar
Tsujimoto M, Yip YK, Vilcek J: Tumor necrosis factor: Specific binding and internalization in sensitive and resistant cells. Proc Natl Acad Sci USA 82:7626–7630, 1985 Google Scholar
Lewis GD, Aggarwal BB, Eessalu TE, Sugarman BJ, Shepard HM: Modulation of the growth of transformed cells by tumor necrosis factor-α and interferon-γ. Cancer Res 47:5382–5385, 1987 Google Scholar
Lee SH, Aggarwal BB, Rinderknecht E, Assisi F, Chiu H: The synergistic and anti-proliferative effect of γ-interferon and human lymphotoxin. J Immunol 133:1083–1086, 1984 Google Scholar
Stone-Wolff DS, Yip YK, Kelker HC, Le J, Henriksen-DeStefano D, Rubin BY, Rinderknecht E, Aggarwal BB, Vilcek J: Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin. J Exp Med 159:828–843, 1984 Google Scholar
Fransen L, van der Heyden J, Ruysschaert R, Fiers W: Recombinant tumor necrosis factor: Its effect and its synergism with interferon-γ on a variety of normal and transformed cell lines. Eur J Clin Oncol 22:419–426, 1985 Google Scholar
Rubin BY, Anderson SL, Sullivan SA, Williamson BD, Carswell E, Old LJ: Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor. J Exp Med 164:1350–1355, 1986 Google Scholar
Spriggs D, Imamura K, Rodriguez C, Horiguchi J, Kufe DW: Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc Natl Acad Sci USA 84:6563–6566, 1987 Google Scholar
Vilcek J, Palombella VJ, Henricksen-DeStefano D, Swenson C, Feinman R, Hirai M, Tsujimoto M: Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 163:632–643, 1986 Google Scholar
Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR: Stimulation of bone resorption and inhibition of bone formation_in vitro_ by human tumor necrosis factors. Nature 319:516–518, 1986 Google Scholar
Lin J-X, Vilcek J: Tumor necrosis factor and interleukin 1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J Biol Chem 262:11908–11911, 1987 Google Scholar
Fernandez-Pol JA: Epidermal growth factor receptor of A431 cells. Characterization of a monoclonal anti-receptor antibody noncompetitive agonist of epidermal growth factor action. J Biol Chem 260:5003–5011, 1985 Google Scholar
Bowen-Pope DF, Dicarleto PE, Ross R: Interactions between the receptors for platelet-derived growth factor and epidermal growth factor. J Cell Biol 96:679–683, 1983 Google Scholar
Collins MKL, Sinnett-Smith JW, Rozengurt E: Platelet-derived growth factor treatment decreases affinity of the epidermal growth factor receptors of Swiss 3T3 cells. J Biol Chem 258:11689–11693, 1983 Google Scholar
Sugarman BJ, Lewis GD, Eessalu TE, Aggarwal BB, Shepard HM: Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res 47:780–786, 1987 Google Scholar
Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA: Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 166:571–576, 1987 Google Scholar
Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alverez-Mon M, Derynck R, Sporn MB, Fauci AS: Production of transforming growth factor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037–1050, 1986 Google Scholar
Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, Fauci AS: Effects of transforming factor-β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136:3916–3920, 1986 Google Scholar
Hunter T: A thousand and one protein kinases. Cell 50:823–829, 1987 Google Scholar
Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray G, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with_neu_ oncogene. Science 230:1132–1139, 1985 Google Scholar
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182, 1987 Google Scholar
Zhou D, Battifora H, Yokota J, Yamamoto T, Cline MJ: Association of multiple copies of the c-_erbB_-2 oncogene with spread of breast cancer. Cancer Res 47:6123–6125, 1987 Google Scholar
Hudziak RM, Schlessinger J, Ullrich A: Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci USA 84:7159–7163, 1987 Google Scholar
Hudziak RM, Lewis GD, Shalaby MR, Eessalu TE, Aggarwal BB, Ullrich A, Shepard HM: Amplified expression of the HER2 oncogene induces TNF-α resistance in NIH 3T3 cells. Proc Natl Acad Sci USA 85:5102–5106, 1988 Google Scholar
Herberman RB, Ortaldo, JR: Natural killer cells: Their role in defenses against disease. Science 214:24–30, 1981 Google Scholar
Peters PM, Ortaldo JR, Shalaby MR, Svedersky LP, Nedwin GE, Bringman TS, Hass PE, Aggarwal BB, Herberman RB, Goeddel DV, Palladino MA: Natural killer-sensitive targets stimulate production of TNF-α but not TNF-β (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J Immunol 137:2592–2598, 1986 Google Scholar
Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA: The lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823–1841, 1982 Google Scholar
Ortaldo JR, Mason LH, Mathieson BJ, Liang SM, Flick DA, Herberman RB: Mediation of mouse natural cytotoxic activity by tumor necrosis factor. Nature 321:700–702, 1986 Google Scholar
Liu CC, Steffen M, King F, Young JD-E: Identification, isolation, and characterization of a novel cytotoxin in murine cytolytic lymphocytes. Cell 51:393–402, 1987 Google Scholar